130 related articles for article (PubMed ID: 20887228)
1. Cohorts for the study of HIV‐1-exposed but uninfected individuals: benefits and limitations.
Horton RE; McLaren PJ; Fowke K; Kimani J; Ball TB
J Infect Dis; 2010 Nov; 202 Suppl 3():S377-81. PubMed ID: 20887228
[TBL] [Abstract][Full Text] [Related]
2. Resistance to HIV-1 infection: lessons learned from studies of highly exposed persistently seronegative (HEPS) individuals.
Kulkarni PS; Butera ST; Duerr AC
AIDS Rev; 2003; 5(2):87-103. PubMed ID: 12876898
[TBL] [Abstract][Full Text] [Related]
3. Natural resistance to HIV infection: lessons learned from HIV‐exposed uninfected individuals.
Pancino G; Saez-Cirion A; Scott-Algara D; Paul P
J Infect Dis; 2010 Nov; 202 Suppl 3():S345-50. PubMed ID: 20887222
[TBL] [Abstract][Full Text] [Related]
4. Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women.
Hirbod T; Broliden K
J Intern Med; 2007 Jul; 262(1):44-58. PubMed ID: 17598814
[TBL] [Abstract][Full Text] [Related]
5. Historical perspective on HIV‐exposed seronegative individuals: has nature done the experiment for us?
Shearer G; Clerici M
J Infect Dis; 2010 Nov; 202 Suppl 3():S329-32. PubMed ID: 20887219
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity in exposed uninfected individuals.
Lopalco L; Pastori C; Barassi C; Furci L; Burastero S; Lillo F; Boeri E; Soldini L; Tambussi G; Lazzarin A; Beretta A; Siccardi AG
J Biol Regul Homeost Agents; 1997; 11(1-2):27-31. PubMed ID: 9418157
[TBL] [Abstract][Full Text] [Related]
7. Genetic and immunological host factors associated with susceptibility to HIV-1 infection.
Buchacz KA; Wilkinson DA; Krowka JF; Koup RA; Padian NS
AIDS; 1998; 12 Suppl A():S87-94. PubMed ID: 9632989
[TBL] [Abstract][Full Text] [Related]
8. [Soluble factors with inhibitory activity against type 1 Human Immunodeficiency Virus].
Zapata W; Montoya CJ; Rugeles MT
Biomedica; 2006 Sep; 26(3):451-66. PubMed ID: 17176009
[TBL] [Abstract][Full Text] [Related]
9. [Mechanisms of resistance to sexual transmission of HIV-1].
Eberhard A; Ponceau B; Biron F; Verrier B
Med Mal Infect; 2005 Nov; 35(11):517-24. PubMed ID: 16253454
[TBL] [Abstract][Full Text] [Related]
10. Genomic approaches to the study of HIV‐1 acquisition.
Telenti A; McLaren P
J Infect Dis; 2010 Nov; 202 Suppl 3():S382-6. PubMed ID: 20887229
[TBL] [Abstract][Full Text] [Related]
11. International symposium on natural immunity to HIV: a gathering of the HIV‐exposed seronegative clan.
Meyers AF; Fowke KR
J Infect Dis; 2010 Nov; 202 Suppl 3():S327-8. PubMed ID: 20887218
[TBL] [Abstract][Full Text] [Related]
12. Immunological profile of heterosexual highly HIV-exposed uninfected individuals: predominant role of CD4 and CD8 T-cell activation.
Suy A; Castro P; Nomdedeu M; García F; López A; Fumero E; Gallart T; Lopalco L; Coll O; Gatell JM; Plana M
J Infect Dis; 2007 Oct; 196(8):1191-201. PubMed ID: 17955438
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis as a mechanism of natural resistance to HIV-1 infection in an exposed but uninfected population.
Velilla PA; Hoyos A; Rojas M; Patiño PJ; Vélez LA; Rugeles MT
J Clin Virol; 2005 Apr; 32(4):329-35. PubMed ID: 15780814
[TBL] [Abstract][Full Text] [Related]
14. Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals.
Montoya CJ; Velilla PA; Chougnet C; Landay AL; Rugeles MT
Clin Immunol; 2006 Aug; 120(2):138-46. PubMed ID: 16624619
[TBL] [Abstract][Full Text] [Related]
15. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
[TBL] [Abstract][Full Text] [Related]
16. Stromal cell-derived factor 1 (SDF1) genetic polymorphism in a sample of healthy individuals, seronegative individuals exposed to human immunodeficiency virus type 1 (HIV-1) and patients infected with HIV-1 from the Brazilian population.
Reiche EM; Watanabe MA; Bonametti AM; Morimoto HK; Morimoto AA; Wiechmann SL; Matsuo T; Miranda HC; Reiche FV; Oliveira KB
Int J Immunogenet; 2006 Apr; 33(2):127-33. PubMed ID: 16611258
[TBL] [Abstract][Full Text] [Related]
17. Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin American and Caribbean countries: the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study.
Mussi-Pinhata MM; Freimanis L; Yamamoto AY; Korelitz J; Pinto JA; Cruz ML; Losso MH; Read JS;
Pediatrics; 2007 Mar; 119(3):e694-704. PubMed ID: 17296782
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between virus and host innate immunity in pediatric HIV-1 infection and disease progression.
Freguja R; Gianesin K; Zanchetta M; De Rossi A
New Microbiol; 2012 Jul; 35(3):249-57. PubMed ID: 22842595
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN).
Tomescu C; Abdulhaqq S; Montaner LJ
Clin Exp Immunol; 2011 May; 164(2):158-69. PubMed ID: 21413945
[TBL] [Abstract][Full Text] [Related]
20. Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks.
Sáez-Cirión A; Versmisse P; Truong LX; Chakrabarti LA; Carpentier W; Barré-Sinoussi F; Scott-Algara D; Pancino G
Retrovirology; 2006 Nov; 3():81. PubMed ID: 17092330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
